FinancialsNYSE
Institutional-grade research for retail investors
SEC EDGAR: CIK 1224608CNO stock profile & AI dashboard →

13F Pro Quality Score

49.1/100

Rank #1,524 of 2,879 stocks

View Financials peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

42.9/100

Profitability

34.9/100

Balance Sheet

38.7/100

Earnings Quality

12.9/100

Free Cash Flow

71.8/100

Institutional Flow

3.3/100

Revenue Scale

76.1/100

Dilution Risk

94.9/100

CNO Stock Analysis & AI Quality Score

AI stock analysis and institutional research for CNO Financial Group, Inc. (CNO), a Financials sector company. 13F Pro's AI-powered ranking engine scores CNO at 49.1/100 on a 32-signal composite quality model, placing it at rank #1,524 of 2,879 stocks — the bottom half of the AI-ranked universe. CNO scores in the top quartile across revenue scale (76.1). Areas of concern include institutional flow (3.3) and earnings quality (12.9), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q1 2026), CNO Financial Group, Inc. reports quarterly revenue of $1.0B, net income of $37.7M, an operating margin of 12.6%. Top institutional holders of CNO by reported 13-F value include BlackRock,, STATE STREET, FRANKLIN RESOURCES, based on the most recent SEC filings. CNO trades on the NYSE exchange and files with the SEC under CIK 1224608. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CNO daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for CNO Financial Group, Inc. directly from SEC EDGAR. CNO Financial Group, Inc.'s 13F Pro composite quality score has ranged between 45 and 64 since 2021, currently 49.1 — a stable long-term trajectory across 28 quarterly and live scoring snapshots.

Revenue

Q1 2026

$1.0B

Net Income

Q1 2026

$37.7M

Free Cash Flow

Q1 2026

$148.8M

Operating Margin

Q1 2026

12.6%

ROIC

Q1 2026

5.2%

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

+25.5% YoY
$4.49BFY 2025
FY20 $3.82BFY21 $4.12BFY22 $3.58BFY25 $4.49B

Net Income

-63.6% YoY
$229.3MFY 2025
FY20 $301.8MFY21 $570.3MFY22 $630.6MFY25 $229.3M

Operating Income

+18.5% YoY
$553.2MFY 2025
FY20 $463.8MFY21 $514.7MFY22 $466.7MFY25 $553.2M

EPS (Diluted)

-57.1% YoY
$2.30FY 2025
FY20 $2.11FY21 $4.35FY22 $5.36FY25 $2.30

Total Assets

+17.1% YoY
$38.79BFY 2025
FY20 $35.34BFY21 $36.20BFY22 $33.13BFY25 $38.79B

Total Debt

FY 2025
FY20 FY21 FY22 FY25

Op. Cash Flow

+36.4% YoY
$675.7MFY 2025
FY20 $735.5MFY21 $598.3MFY22 $495.4MFY25 $675.7M

AI Insight: CNO Financial Trends

CNO revenue hit a new high of $1,189M in Q3 2025, but net income remains thin and volatile, limiting bottom-line conviction.

Revenue grew from $1,066M in Q2 2024 to $1,189M in Q3 2025, a ~12% rise, though Q1 2026 dipped to $1,030M.

Net income is highly erratic, swinging from $166M in Q4 2024 to $22M in Q1 2025 and $38M in Q1 2026.

Operating cash flow improved from $111M in Q2 2024 to $198M in Q3 2025, suggesting underlying cash generation is strengthening.

Equity held relatively stable, ranging from $2,429M in Q2 2024 to $2,638M in Q4 2025, with Q1 2026 declining to $2,498M.

Operating income dropped sharply to $105M in Q1 2025 and $112M in Q2 2025 before recovering — seasonal or structural weakness warrants monitoring.

Net income in Q1 2026 of $38M remains well below the $93M posted in Q4 2025, continuing the pattern of weak first quarters.

Total debt data is absent across all periods, making leverage and capital structure assessment impossible.

AI Insight: CNO Ratio Trends

CNO's profitability shows persistent Q1 seasonality weakness, with Q1 2026 OpMargin at 12.6% and ROIC at 20.8% — both near cycle lows.

OpMargin follows a clear seasonal pattern: Q4 peaks (15.8% in Q4 2024, 15.2% in Q4 2025) consistently give way to Q1 troughs (10.4% in Q1 2025, 12.6% in Q1 2026).

ROIC contracted from a peak of 27.7% in Q4 2024 to 20.8% in Q1 2026, reflecting both seasonality and a softer profitability trend.

NPM is highly volatile quarter to quarter, ranging from 0.8% in Q3 2024 to 15.1% in Q4 2024, suggesting significant one-off or actuarial items.

Q1 2026 ROIC of 20.8% is the second-lowest in the dataset — monitor whether Q2 2026 rebounds toward the 17–25% range seen historically.

TTM NPM of 5.4% sits well below Q4 2024's 15.1%, partly dragged by weak Q1 and Q3 quarters — watch for sustained improvement in core earnings quality.

D/E data is unavailable across all periods; absence limits leverage assessment, a key risk metric for an insurance holding company.

Get alerted when CNO's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for CNO Financial Group, Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of CNO

Put CNO on your watchlist

Track score changes the day CNO Financial Group, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is CNO a good stock to buy?

13F Pro's AI-powered analysis of CNO Financial Group, Inc. (CNO) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Financials sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for CNO are available on the CNO stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own CNO?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling CNO. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of CNO Financial Group, Inc.'s investment landscape.